Patrizia Ferroni Selected Research

Patrizia Ferroni Research Topics

Disease

49	Neoplasms (Cancer) 04/2021 - 01/2003
18	Venous Thromboembolism 03/2021 - 11/2012
14	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2003
12	Migraine Disorders (Migraine) 01/2020 - 09/2013
11	Inflammation (Inflammations) 09/2016 - 06/2003
9	Breast Neoplasms (Breast Cancer) 08/2018 - 09/2009
6	Thrombosis (Thrombus) 12/2013 - 03/2004
5	Neoplasm Metastasis (Metastasis) 02/2017 - 01/2003
5	Atherosclerosis 12/2014 - 06/2003
4	Headache (Headaches) 01/2019 - 01/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2013 - 02/2008
4	Essential Hypertension 07/2012 - 02/2008
4	Hypercholesterolemia 08/2004 - 06/2003
3	Hemorrhage 05/2020 - 01/2015
3	Obesity 07/2017 - 05/2014
3	Type 2 Diabetes Mellitus (MODY) 07/2017 - 05/2013
3	Pain (Aches) 05/2017 - 01/2015
3	Stroke (Strokes) 01/2015 - 06/2011
3	Activated Protein C Resistance (APC Resistance) 09/2013 - 11/2012
3	Lung Neoplasms (Lung Cancer) 11/2012 - 01/2003
3	Hypertension (High Blood Pressure) 07/2012 - 03/2008
3	Myocardial Infarction 06/2007 - 09/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2006 - 01/2003
2	Prescription Drug Overuse 08/2019 - 01/2017
2	Disease Progression 01/2018 - 09/2004
2	Thromboembolism 01/2017 - 01/2010
2	Triple Negative Breast Neoplasms 10/2016 - 01/2016
2	Insulin Resistance 01/2016 - 01/2015
2	Heart Diseases (Heart Disease) 12/2014 - 04/2004
2	Sarcoma (Soft Tissue Sarcoma) 05/2013 - 07/2012
2	Genetic Predisposition to Disease (Genetic Predisposition) 06/2011 - 09/2009
2	Fibrosis (Cirrhosis) 02/2011 - 09/2002
2	Chest Pain (Chest Pains) 06/2007 - 04/2004
2	Atherosclerotic Plaque (Atheroma) 09/2003 - 06/2003
1	Microsatellite Instability 01/2021

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2003
9	CytokinesIBA 01/2019 - 01/2003
9	SelectinsIBA 02/2011 - 01/2003
7	Pharmaceutical PreparationsIBA 01/2020 - 03/2007
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2012
6	Bevacizumab (Avastin)FDA Link 07/2017 - 01/2010
6	Protein CIBA 01/2016 - 01/2010
5	LipidsIBA 01/2017 - 06/2003
5	Thrombin FDA Link 11/2016 - 01/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2009
5	CD40 Ligand (CD40L)IBA 05/2013 - 06/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 09/2002
4	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 01/2015
4	Insulin (Novolin)FDA Link 07/2017 - 05/2013
4	Oxidants (Oxidizing Agents)IBA 02/2017 - 08/2004
4	PlatinumIBA 10/2014 - 06/2011
4	fibrin fragment D (D-dimer)IBA 03/2014 - 01/2003
4	C-Reactive ProteinIBA 03/2008 - 06/2003
4	P-SelectinIBA 03/2008 - 01/2004
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 12/2013
3	AnticoagulantsIBA 05/2020 - 01/2015
3	AdipokinesIBA 01/2019 - 08/2009
3	Biological ProductsIBA 08/2018 - 06/2003
3	AntioxidantsIBA 01/2018 - 06/2011
3	Blood Glucose (Blood Sugar)IBA 07/2017 - 01/2016
3	Messenger RNA (mRNA)IBA 10/2016 - 06/2010
3	VaccinesIBA 10/2016 - 05/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 06/2011
3	EnzymesIBA 01/2015 - 04/2004
3	AdiponectinIBA 05/2014 - 01/2007
3	ParaffinIBA 01/2014 - 07/2012
3	Carcinoembryonic AntigenIBA 06/2010 - 01/2003
3	Fibrinogen (Factor I)FDA Link 04/2004 - 06/2003
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 09/2016
2	Dopamine beta-HydroxylaseIBA 08/2019 - 01/2015
2	NeuropeptidesIBA 01/2019 - 05/2017
2	Peptides (Polypeptides)IBA 01/2019 - 05/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2017 - 12/2016
2	Phenobarbital (Luminal)FDA Link 02/2017 - 10/2016
2	Brachyury protein (Brachyury)IBA 10/2016 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 05/2014
2	ThromboxanesIBA 09/2016 - 08/2011
2	Hormones (Hormone)IBA 01/2016 - 05/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2014 - 05/2013
2	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 12/2013
2	LeptinIBA 05/2014 - 08/2009
2	Plasminogen Activator Inhibitor 1IBA 03/2014 - 09/2009
2	Hemostatics (Antihemorrhagics)IBA 05/2013 - 06/2003
2	Thromboxane A2 (A2, Thromboxane)IBA 05/2013 - 08/2011
2	Antihypertensive Agents (Antihypertensives)IBA 07/2012 - 02/2008
2	Cytotoxins (Cytolysins)IBA 06/2011 - 03/2007
2	E-SelectinIBA 06/2010 - 01/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2009 - 10/2003
2	von Willebrand FactorIBA 03/2008 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 06/2007 - 01/2003
2	antithrombin III-protease complexIBA 01/2004 - 01/2003
2	InterleukinsIBA 10/2003 - 09/2003
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2003 - 01/2003
1	Circulating Tumor DNAIBA 12/2020
1	Antineoplastic Agents (Antineoplastics)IBA 05/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2020

Therapy/Procedure

20	Therapeutics 04/2021 - 03/2004
19	Drug Therapy (Chemotherapy) 01/2021 - 08/2006
2	Treatment Delay 03/2021 - 01/2019
2	Precision Medicine 01/2019 - 01/2017